Shahrokh Shariat Explained

Shahrokh Shariat
Birth Date:20 September 1973
Birth Place:Tehran, Imperial State of Iran
Nationality:Austrian
Education:University of Vienna
Baylor College of Medicine
University of Texas Southwestern Medical Center
Memorial Sloan-Kettering Cancer Center
Alma Mater:University of Vienna
Baylor College of Medicine
University of Texas Southwestern Medical Center
Memorial Sloan-Kettering Cancer Center
Occupation:Physician, Surgeon, Oncologist, Urologist
Website:

    Shahrokh François Shariat (born September 20, 1973) is currently professor and chairman of the Department of Urology, Medical University of Vienna, Vienna General Hospital, Vienna, Austria, [1] and doctor honoris causa, Semmelweis University, Budapest, Hungary. He has published more than 1500 peer-reviewed research papers, more than 600 non-peer-reviewed papers, and 26 book chapters. Shahrokh Shariat specializes in treating urologic malignancies. He has been voted as the most influential urologist in 2020[2] and also the most cited prostate cancer researcher[3] in the German-speaking area.

    Research and areas of focus

    As a specialist for treating urological cancers[4] [5] [6] Shariat is the holder of four patents stemming from his research into prostate cancer and bladder cancer. Furthermore, he is currently spearheading several collaborative multicenter groups (Bladder Cancer Research Consortium, The Bladder Cancer Detection Group, and The Upper Tract Urothelial Carcinoma Collaboration) and prospective clinical trials.

    Shariat's research focuses on the following areas:

    1. Translational research in robotic prostatectomy and prostate cancer
    2. Translational research in bladder cancer and upper tract urothelial carcinoma
    3. Gene, vaccine and immunotherapies for urologic diseases with focus on bladder and prostate cancers
    4. Minimal invasive instrumental treatment modalities for benign prostate hypertrophy and prostate cancer.

    References

    1. Web site: Shahrokh Shariat awarded honorary doctorate by Carol Davila University of Medicine and Pharmacy . 5 July 2022.
    2. Web site: Big-Data-Analyse von SCI-Papieren, die 2020 in der Urologie veröffentlicht wurden . 5 July 2022.
    3. Web site: Alle gegen Prostatakrebs Publikationsanalyse 2010-2019: Urologische Forschung von Mario Rembold, Laborjournal 1-2/2021 . Laborjournal . 5 July 2022.
    4. News: Reiter-Reitbauer . Magdalena . Über Blasenkrebs sprechen – aber richtig . 5 July 2022 . krebsratgeber.at.
    5. News: Kruckenhauser . Pia . Spermageddon: Können die Männer bald keine Kinder mehr zeugen? . 5 July 2022 . DerStandard.
    6. News: STOP Blasenkrebs Mai ist der internationale Blasenkrebsmonat! . 5 July 2022 . Kronen Zeitung.

    External links